• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov13
Oncolytics Biotech released FY2025 9 Months earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -0.2067
04:00
Oncolytics Biotech released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.102 (forecast USD -0.0616)
04:00
Oct28
Oncolytics Biotech Reports 30% Response Rate for Anal Cancer Combination Therapy
11:31
Aug8
Oncolytics Biotech released FY2025 Q2 earnings on August 8 Pre-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0494 (forecast USD -0.0737)
13:30
Oncolytics Biotech released FY2025 Semi-Annual Earnings on August 8 Pre-Market EST, with actual revenue of USD 0 and EPS of USD -0.1045
13:30
Aug1
Oncolytics Biotech to Release FY2025 Q2 Earnings on August 8 Pre-Market EST, Forecast Revenue USD 0, EPS USD -0.0729
00:05

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -10.34 M, EPS -0.102

Aug8
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -4.5 M, EPS -0.0494

May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -4.671 M, EPS -0.0551

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
RPGL
0.8222
+212.27%
+0.561
BNAI
2.210
+84.17%
+1.000
CCTG
0.1960
+50.42%
+0.065
GVH
3.810
+46.54%
+1.210
GLSI
28.550
+38.02%
+7.865
SOPA
2.461
+35.20%
+0.649
SIDU
2.609
+35.18%
+0.675
MASK
0.2444
+33.55%
+0.062
CCHH
0.6388
+26.05%
+0.135
ALISR
0.4459
+23.86%
+0.086
View More